Agilent Technologies, Inc. (NYSE:A) had its target price upped by J P Morgan Chase & Co to $75.00 in a research note published on Tuesday, The Fly reports. They currently have an overweight rating on the medical research company’s stock.

Other analysts also recently issued research reports about the stock. Jefferies Group LLC reissued a buy rating and set a $66.00 target price on shares of Agilent Technologies in a research report on Wednesday, August 9th. Zacks Investment Research raised shares of Agilent Technologies from a hold rating to a buy rating and set a $76.00 price objective on the stock in a report on Tuesday, October 31st. Robert W. Baird reaffirmed a buy rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Friday, October 20th. Janney Montgomery Scott upped their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the company a buy rating in a report on Wednesday, August 16th. Finally, Deutsche Bank AG set a $75.00 price objective on shares of Agilent Technologies and gave the company a buy rating in a report on Tuesday. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Agilent Technologies has a consensus rating of Buy and a consensus price target of $68.34.

Agilent Technologies (NYSE:A) opened at $69.36 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.76 and a current ratio of 3.30. The company has a market cap of $22,106.37, a P/E ratio of 28.98, a P/E/G ratio of 2.07 and a beta of 1.27. Agilent Technologies has a 52 week low of $42.92 and a 52 week high of $70.81.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.62 by $0.05. The firm had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.59 EPS. analysts forecast that Agilent Technologies will post 2.58 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. The ex-dividend date is Friday, December 29th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a yield of 0.86%. Agilent Technologies’s dividend payout ratio is 25.24%.

In other Agilent Technologies news, Director Boon Hwee Koh sold 4,500 shares of the company’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the completion of the sale, the chief executive officer now owns 327,882 shares of the company’s stock, valued at $22,951,740. The disclosure for this sale can be found here. Insiders have sold 107,709 shares of company stock worth $7,195,576 over the last three months.

Several hedge funds and other institutional investors have recently modified their holdings of A. JPMorgan Chase & Co. raised its position in shares of Agilent Technologies by 45.2% in the second quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after buying an additional 3,779,099 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Agilent Technologies by 720.6% in the second quarter. PNC Financial Services Group Inc. now owns 1,131,276 shares of the medical research company’s stock valued at $67,097,000 after purchasing an additional 993,414 shares during the period. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in shares of Agilent Technologies in the second quarter valued at about $58,693,000. TimesSquare Capital Management LLC purchased a new stake in shares of Agilent Technologies in the third quarter valued at about $58,550,000. Finally, Voya Investment Management LLC grew its holdings in shares of Agilent Technologies by 444.0% in the second quarter. Voya Investment Management LLC now owns 1,032,128 shares of the medical research company’s stock valued at $61,215,000 after purchasing an additional 842,398 shares during the period.

TRADEMARK VIOLATION NOTICE: “J P Morgan Chase & Co Increases Agilent Technologies, Inc. (A) Price Target to $75.00” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/j-p-morgan-chase-co-increases-agilent-technologies-inc-a-price-target-to-75-00/1725049.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

The Fly

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.